Pfizer and BioNTech claim that their vaccine protects for 6 months

The American drug manufacturer Pfizer and its German partner BioNTech announced on Thursday that their coronavirus vaccine is effective for six months after the second dose.

A baseline phase 3 study showed that the injection was “91.3% effective against COVID-19, measured seven days to six months after the second dose,” the joint statement said.

While the U.S. Centers for Disease Control and Prevention found the vaccine to be 100% effective against serious illness, the Food and Drug Administration (FDA) said it was 95.3% effective.

According to the statement, safety data collected from more than 12,000 vaccinated participants who had a follow-up of at least six months after the second dose showed a “favorable safety and tolerability profile”.

“These data support the favorable efficacy and safety profile of our vaccine and allow us to apply for a US FDA license for biologics,” said Albert Burla, chairman and CEO of Pfizer.

  The first medical shopping complex is opened in the UAE

“The high efficacy of the vaccine, which is observed within six months after the second dose and against the variant common in South Africa, gives additional confidence in the overall effectiveness of our vaccine,” Burla continued.

The study involved 46,307 people.

Meanwhile, according to media reports, up to 15 million doses of Johnson & Johnson vaccine, produced at a plant in Baltimore, Maryland, were damaged due to human error.

The confusion has led to delays in future supplies to the United States as the FDA investigates, The New York Times reported on Wednesday.

  The first medical shopping complex is opened in the UAE
Follow us on Google News

Also read


UK has identified 30 cases of blood clots after the AstraZeneca vaccine

The British regulators said they found 30 rare cases of blood clots after using the AstraZeneca Covid-19 vaccine, which is 25 more than previously...

The Johnson & Johnson COVID-19 vaccine series has not passed quality control

The consignment of COVID-19 vaccine from Johnson & Johnson does not meet quality standards and cannot be used, the drug giant said on Wednesday. The...

CyberKnife is an almost ideal method of cancer treatment. Spizhenko Clinic

Spizhenko Clinic is the first medical center in Eastern Europe to use a robotic CyberKnife system for non-surgical treatment of cancer and vascular pathologies....

Last news